It was announced yesterday that the STEP trial will be unblinded; all 3,000 participants will be told whether they received vaccine or placebo and informed of their anti-adenovirus antibody titer.
Merck/HVTN Press Release
San Francisco Chronicle
Baltimore Sun
Seattle Post Intelligencer
Comments